Search

everythinglearnresearchcommunity

for

Search:↓

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

PRF lysates reduce inflammation in cancer cells and boost immune response in healthy oral cells.

IL-1 signaling is crucial for hair follicle stem cell growth and wound healing.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Next-generation Treg therapies could help achieve lasting immune tolerance in type 1 diabetes.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Certain immune cells, when activated by specific signals, can encourage hair growth.

Overexpressing PKCα in mice skin increases inflammation but doesn't affect tumor growth.

Type I interferons play a key role in the development of various skin diseases.

IL-1 promotes fat cell growth in skin, while WNT inhibits it and encourages scar formation.

Engineered cytokines show promise for improving tissue healing and safety in regenerative medicine.

SCF and ET-1 together significantly increase skin pigmentation and melanin production.

Inhibiting IL-17 and IL-23 improves wound healing in obese, diabetic mice by promoting healing macrophages.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

Reprogramming macrophages to resolve inflammation can help reduce severe COVID-19 complications.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

SPT6 prevents excessive skin inflammation by blocking a feedback loop.

B cells can both help and hinder the body's defense against melanoma.

Skin cells and immune cells change in a skin condition called hidradenitis suppurativa, and a certain treatment can improve these changes.

Blocking Wnt signaling in young mice causes thymus shrinkage and cell loss, but recovery is possible when the block is removed.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

TNF-alpha inhibitors can cause various immune-related skin issues.

Memory regulatory T cells need IL-7, not IL-2, to stay in peripheral tissues.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Enhancing Tregs can protect against alopecia areata.

Blocking TSLP reduces skin inflammation and cell overgrowth in psoriasis.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Interleukin 6 may help protect skin without causing inflammation.

Immune cells and cytokines significantly affect pathological scar development.